173 related articles for article (PubMed ID: 25151967)
1. Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism.
Teh JT; Zhu WL; Ilkayeva OR; Li Y; Gooding J; Casey PJ; Summers SA; Newgard CB; Wang M
Oncogene; 2015 Jun; 34(25):3296-304. PubMed ID: 25151967
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer.
Manu KA; Chai TF; Teh JT; Zhu WL; Casey PJ; Wang M
Mol Cancer Ther; 2017 May; 16(5):914-923. PubMed ID: 28167504
[TBL] [Abstract][Full Text] [Related]
3. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
Pan Q; Liu R; Banu H; Ma L; Li H
Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting prenylation augments chemotherapy efficacy in renal cell carcinoma through dual inhibition on mitochondrial respiration and glycolysis.
Huang J; Yang X; Peng X; Huang W
Biochem Biophys Res Commun; 2017 Nov; 493(2):921-927. PubMed ID: 28943437
[TBL] [Abstract][Full Text] [Related]
6. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation.
Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L
Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868
[TBL] [Abstract][Full Text] [Related]
7. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.
Wang M; Tan W; Zhou J; Leow J; Go M; Lee HS; Casey PJ
J Biol Chem; 2008 Jul; 283(27):18678-84. PubMed ID: 18434300
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth.
Wang M; Hossain MS; Tan W; Coolman B; Zhou J; Liu S; Casey PJ
Oncogene; 2010 Sep; 29(35):4959-70. PubMed ID: 20622895
[TBL] [Abstract][Full Text] [Related]
9. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
Cushman I; Casey PJ
J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
[TBL] [Abstract][Full Text] [Related]
10. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
Zhu Y; Hu Q; Li H
Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
[TBL] [Abstract][Full Text] [Related]
11. Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt).
Ramanujulu PM; Yang T; Yap SQ; Wong FC; Casey PJ; Wang M; Go ML
Eur J Med Chem; 2013 May; 63():378-86. PubMed ID: 23514631
[TBL] [Abstract][Full Text] [Related]
12. ICMT contributes to hepatocellular carcinoma growth, survival, migration and chemoresistance via multiple oncogenic pathways.
Xu J; Zhu Y; Wang F; Zhou Y; Xia G; Xu W
Biochem Biophys Res Commun; 2019 Oct; 518(3):584-589. PubMed ID: 31451223
[TBL] [Abstract][Full Text] [Related]
13. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
Chai TF; Manu KA; Casey PJ; Wang M
Oncogene; 2020 Jul; 39(31):5373-5389. PubMed ID: 32561852
[TBL] [Abstract][Full Text] [Related]
14. The isoprenoid substrate specificity of isoprenylcysteine carboxylmethyltransferase: development of novel inhibitors.
Anderson JL; Henriksen BS; Gibbs RA; Hrycyna CA
J Biol Chem; 2005 Aug; 280(33):29454-61. PubMed ID: 15946942
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt).
Baron RA; Casey PJ
BMC Biochem; 2004 Dec; 5():19. PubMed ID: 15625008
[TBL] [Abstract][Full Text] [Related]
16. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ICMT induces endothelial cell apoptosis through GRP94.
Lu Q; Harrington EO; Newton J; Jankowich M; Rounds S
Am J Respir Cell Mol Biol; 2007 Jul; 37(1):20-30. PubMed ID: 17347446
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent inhibition of isoprenylcysteine carboxyl methyltransferase by indole-based small molecules.
Baron RA; Peterson YK; Otto JC; Rudolph J; Casey PJ
Biochemistry; 2007 Jan; 46(2):554-60. PubMed ID: 17209565
[TBL] [Abstract][Full Text] [Related]
19. A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia.
Marín-Ramos NI; Balabasquer M; Ortega-Nogales FJ; Torrecillas IR; Gil-Ordóñez A; Marcos-Ramiro B; Aguilar-Garrido P; Cushman I; Romero A; Medrano FJ; Gajate C; Mollinedo F; Philips MR; Campillo M; Gallardo M; Martín-Fontecha M; López-Rodríguez ML; Ortega-Gutiérrez S
J Med Chem; 2019 Jul; 62(13):6035-6046. PubMed ID: 31181882
[TBL] [Abstract][Full Text] [Related]
20. Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function.
Svensson AW; Casey PJ; Young SG; Bergo MO
Methods Enzymol; 2006; 407():144-59. PubMed ID: 16757321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
